Schematic illustration of the preparation of FeS2-based nanoparticles (pyrite-based NPs) and their roles in NIR II-enhanced CDT synergistic therapy of osteosarcoma. (A) The fabrication process of FeS2@CP NPs. (B) The therapeutic mechanism of FeS2@CP NPs in the treatment of osteosarcoma